Antimicrobial Effects of Chemically Functionalized and/or Photo-Heated Nanoparticles.
antibacterial agents
antibiotic resistance
gold nanoparticles
plasmonic resonance
thermal inactivation
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
02 Apr 2019
02 Apr 2019
Historique:
received:
25
02
2019
revised:
26
03
2019
accepted:
27
03
2019
entrez:
17
4
2019
pubmed:
17
4
2019
medline:
17
4
2019
Statut:
epublish
Résumé
Antibiotic resistance refers to when microorganisms survive and grow in the presence of specific antibiotics, a phenomenon mainly related to the indiscriminate widespread use and abuse of antibiotics. In this framework, thanks to the design and fabrication of original functional nanomaterials, nanotechnology offers a powerful weapon against several diseases such as cancer and pathogenic illness. Smart nanomaterials, such as metallic nanoparticles and semiconductor nanocrystals, enable the realization of novel drug-free medical therapies for fighting against antibiotic-resistant bacteria. In the light of the latest developments, we highlight the outstanding capabilities of several nanotechnology-inspired approaches to kill antibiotic-resistant bacteria. Chemically functionalized silver and titanium dioxide nanoparticles have been employed for their intrinsic toxicity, which enables them to exhibit an antimicrobial activity while, in a different approach, photo-thermal properties of metallic nanoparticles have been theoretically studied and experimentally tested against several temperature sensitive (mesophilic) bacteria. We also show that it is possible to combine a highly localized targeting with a plasmonic-based heating therapy by properly functionalizing nanoparticle surfaces with covalently linked antibodies. As a perspective, the utilization of properly engineered and chemically functionalized nanomaterials opens a new roads for realizing antibiotic free treatments against pathogens and related diseases.
Identifiants
pubmed: 30986924
pii: ma12071078
doi: 10.3390/ma12071078
pmc: PMC6479897
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Air Force Office of Scientific Research
ID : FA9550-18-1-0038
Références
Science. 2002 Aug 16;297(5584):1160-3
pubmed: 12183624
Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S77-98
pubmed: 12460717
Chem Rev. 2003 Feb;103(2):577-644
pubmed: 12580643
Bioconjug Chem. 2004 Jul-Aug;15(4):897-900
pubmed: 15264879
J Nanobiotechnology. 2004 Dec 08;2(1):12
pubmed: 15588280
Biotechnol Bioeng. 2005 Apr 5;90(1):59-63
pubmed: 15723325
J Hosp Infect. 2006 Jan;62(1):58-63
pubmed: 16099072
Toxicol Sci. 2006 Jan;89(1):42-50
pubmed: 16177233
Water Res. 2006 Nov;40(19):3527-32
pubmed: 17011015
Langmuir. 2006 Oct 24;22(22):9322-8
pubmed: 17042548
Environ Sci Technol. 2006 Oct 1;40(19):6151-6
pubmed: 17051814
Sci Total Environ. 2007 Feb 15;373(2-3):572-5
pubmed: 17173953
Skin Pharmacol Physiol. 2007;20(3):148-54
pubmed: 17230054
Nanomedicine. 2007 Mar;3(1):95-101
pubmed: 17379174
Nanomedicine. 2007 Jun;3(2):168-71
pubmed: 17468052
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Apr;75(4 Pt 2):046302
pubmed: 17500988
Lasers Med Sci. 2008 Jul;23(3):217-28
pubmed: 17674122
Nano Lett. 2007 Nov;7(11):3523-7
pubmed: 17963415
Nano Lett. 2008 Jan;8(1):302-6
pubmed: 18062714
Toxicol Appl Pharmacol. 2008 Apr 15;228(2):200-11
pubmed: 18261754
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1307-15
pubmed: 18555555
Environ Sci Technol. 2008 Sep 1;42(17):6730-5
pubmed: 18800556
Water Res. 2008 Nov;42(18):4591-602
pubmed: 18804836
Biotechnol Adv. 2009 Jan-Feb;27(1):76-83
pubmed: 18854209
Acc Chem Res. 2008 Dec;41(12):1842-51
pubmed: 19053240
J Biomed Opt. 2008 Nov-Dec;13(6):064031
pubmed: 19123677
Adv Drug Deliv Rev. 2010 Mar 8;62(3):339-45
pubmed: 19909777
J Biomed Mater Res B Appl Biomater. 2010 May;93(2):557-61
pubmed: 20225250
APMIS. 2010 Sep 1;118(9):621-39
pubmed: 20718714
Adv Mater. 2010 Nov 24;22(44):4925-43
pubmed: 20818618
Nature. 2011 Aug 31;477(7365):457-61
pubmed: 21881561
Front Microbiol. 2011 Sep 28;2:203
pubmed: 22046172
Crit Rev Microbiol. 2015 Feb;41(1):101-8
pubmed: 23862575
Langmuir. 2014 Mar 18;30(10):2608-18
pubmed: 24564705
Plasmonics. 2014;9:581-593
pubmed: 24834019
Future Med Chem. 2015;7(4):493-512
pubmed: 25875875
Phys Chem Chem Phys. 2015 Aug 21;17(31):20281-7
pubmed: 26189931
Iran Biomed J. 2015;19(4):233-9
pubmed: 26220727
Microbiol Spectr. 2016 Apr;4(2):
pubmed: 27227291
Adv Healthc Mater. 2016 Aug;5(16):2122-30
pubmed: 27336752
ACS Nano. 2017 Jan 24;11(1):1012-1025
pubmed: 28009498
FEMS Microbiol Rev. 2017 May 1;41(3):276-301
pubmed: 28369412
Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:54-58
pubmed: 28866198
J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):300-305
pubmed: 29109626
Curr Opin Microbiol. 2017 Oct;39:106-112
pubmed: 29154024
Environ Sci Technol. 2018 Jan 2;52(1):205-213
pubmed: 29240431
Science. 2018 Oct 12;362(6411):207-212
pubmed: 30309949
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Beilstein J Nanotechnol. 2018 Oct 8;9:2657-2664
pubmed: 30416916